C2Sense Inc.
Watertown, MA
- UEI
- FH5NDXG3GXL3
- CAGE
- 6WZ31
- Primary NAICS
- 541713 Research and Development in Nanotechnology
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 480 Arsenal St #110, Watertown, MA 02472, USA
- Website
- hyperionbiosystems.com
- Founded
- 2013
- Industry
-
- Industrials
- Commercial & Professional Services
- Professional Services
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| The Johns Hopkins University Applied Physics Laboratory LLC | HQ003423F0471 | $51,300 |
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sbir phase i: ethylene sensor for monitoring produce ripeness and reducing spoilage of food | National Science Foundation | $145,500 |
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Board Of Regents Of Nevada System Of Higher Education | 2452585 | $447,951 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| DCN Diagnostics | Carlsbad, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Hemex Health Inc. | Portland, OR | 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing |
About the company
C2Sense Inc. develops advanced optical sensing systems that provide unprecedented sensitivity and specificity at extremely low cost. In the medical space, C2Sense's "Halo" platform uses fluorescence to convert conventional lateral flow assays into highly sensitive and quantitative diagnostic tests. The company is a for-profit corporate entity and manufacturer of goods registered to receive awards from the U.S. federal government.
C2Sense Inc. has primarily worked as a subcontractor on federal contracts. The company has received multiple sub-awards from MRIGlobal to develop europium-based lateral flow assays (LFAs) for detecting Staphylococcus enterotoxin B (SEB), a potential bioterrorism agent. C2Sense has also collaborated with MRIGlobal on a project to perform design for manufacturing (DFM) review, fabricate prototype readers, and test the resultant with recombinant protein and live virus, with the goal of tuning the system for wastewater pathogen detection. The work spans areas such as optical sensing, lateral flow assay development, and prototype fabrication for pathogen detection applications.
Quick answers
Is C2Sense Inc. registered in SAM.gov?
Yes. C2Sense Inc.'s SAM.gov registration is active through September 25, 2027.
What is C2Sense Inc.'s most recent federal award?
C2Sense Inc.'s most recent federal grant award is Sbir phase i: ethylene sensor for monitoring produce ripeness and reducing spoilage of food (1345915), from National Science Foundation, on January 1, 2014.
On GovTribe
See C2Sense Inc.'s full federal record
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors